Award Notice
Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response · Sol. BAA-23-100-SOL-00004
More open Office of Assistant Secretary for Preparedness and Response contracts
No deadlineClosed
This contract has been awarded
Awarded to Scynexis, Inc. for $214M on Sep 25, 2026.
Search open federal contracts for similar work.
AI summary Beta
No AI summary for this notice yet.
Save it to generate your own AI brief in its bid workspace: a plain-English summary, the red flags, and how well your business fits.
Key facts
- Posted
- Sep 25, 2026
- Notice type
- Award Notice
- Solicitation
- BAA-23-100-SOL-00004
- Agency
- Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Office
- Barda - Aspr / Daappo / Barda DCMA
- Place of performance
- Jersey City, NJ, 07302
- Contracting contact
- Audrey Gloveraudrey.glover@hhs.gov